99% of administered nanoparticles will accumulate and sequester in the liver after
administration into the body. This results in reduced delivery to the targeted diseased tissue …

In recent years, considerable efforts have been spent in the development of magnetic
nanoparticles (MNPs), the understanding of their behavior, and the improvement of their …

Hepatobiliary magnetic resonance imaging (MRI) can inform the diagnosis of liver tumours
in patients with liver cirrhosis and hepatitis. However, its clinical utility has been hampered …

Hepatobiliary diseases are serious universal health concerns that affects the liver and is
responsible for around 2 million deaths annually. The limitations of standard drug-delivery …

Iron oxide nanoparticle (IONP) with unique magnetic property and high biocompatibility
have been widely used as magnetic resonance imaging (MRI) contrast agent (CA) for long …

Hepatocyte resident afflictions continue to affect the human population unabated. The
asialoglycoprotein receptor (ASGPR) is primarily expressed on hepatocytes and minimally …

Several new types of carriers and technologies have been implemented in the recent past to
improve traditional enzyme immobilization which aimed to enhance enzyme loading, activity …

In recent years, although many review articles have been presented about bioapplications of
magnetic nanoparticles by some research groups with different expertise such as chemistry …

Nanoparticles with cores composed of inorganic materials such as noble, magnetic metals,
their alloys and oxides, and semiconductors have been most studied and have vast potential …

The specific targeting of either tumor cells or immune cells in vivo by carefully designed and
appropriately surface-functionalized nanocarriers may become an effective therapeutic …